Products

What will AGI do for Arbekacin?

This classification denotes an aminoglycoside antibiotic with the molecular formula C22H44N6O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G7V6SLI20L, chemically known as o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1->4)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1->6))-n-((2s)-4-amino-2-hydroxybutyryl)-2-deoxy-l-streptamine but generally known as arbekacin, which bears US NIH Compound Identifier 68682. Arbekacin most often comes in base and sulfate forms. European Medicines Agency schedules Arbekacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05554MIG. The term ARBEKACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules arbekacin in its Anatomical Therapeutic Chemical (ATC) Classification. ARBEKACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule arbekacin under HS 29419000 and SITC 54139. As of Q4 2014, ARBEKACIN remains the US FDA Preferred Term for this commodity. Arbekacin bears US NLM identifiers UMLS ID C0062073 and NCI Concept Code C76145. SMILES: O(C1C(NC(=O)C(O)CCN)CC(N)C(OC2OC(CCC2N)CN)C1O)C1OC(C(O)C(N)C1O)CO.